Month: June 2026

For decades, men have faced a coin flip after a high PSA result: biopsy or nothing. A major study of nearly 18,000 men suggests there's a smarter middle step — MRI. Used as a filter between PSA and biopsy, it identifies who truly needs further evaluation and cuts unnecessary overtreatment in half. keep reading

Your prostate has a secret line of defense that scientists only just discovered. Specialized immune cells called T cells travel to the prostate and stay there for months or years, standing guard against infection. Now researchers believe the same process that protects mouse prostates may apply to humans, and it could open a new door in prostate cancer treatment. keep reading

A New York Times reporter did solid work exposing the harms of PSA overscreening but missed something important. Between radical treatment and watchful waiting sits focal therapy: a minimally invasive, targeted option that the NCCN now recognizes, and that mpMRI makes more precise than ever. keep reading

Focal therapy destroys a prostate tumor while leaving healthy tissue intact. But once treatment is done, how do doctors know if it worked? A structured follow-up protocol using mpMRI is the current standard. Now a newly proposed PSMA-based scoring system called PSMA-FAB is aiming to complement that approach. keep reading